Breathe Well Live Well
|
Study explores new approaches to prevent fall asthma exacerbations in …
News-Medical.net Experts from Children's Hospital Colorado (Children's Colorado) co-led a team of researchers in studying new approaches to reducing fall asthma exacerbations in pediatric patients. Their findings were released online in late October and published in … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Mepolizumab 100mg SC; Drug: Albuterol/salbutamol MDIs; Drug: Omalizumab
Sponsor: GlaxoSmithKline
Not yet recruiting – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
 |
Related Articles |
Medical care and treatment of allergic rhinitis. A population-based cohort study based on routine healthcare utilization data.
Allergy. 2016 Jan 8;
Authors: Schmitt J, Stadler E, Küster D, Wüstenberg EG
Abstract
BACKGROUND: Health services research on medical care and treatment of allergic rhinitis (AR) is scarce.
OBJECTIVES: To investigate the prevalence, incidence, comorbidities, and treatment of AR in a realistic setting.
METHODS: A cohort of 1,811,094 German National Health Insurance beneficiaries in 2005 was followed until 2011. To avoid misclassification, the ICD-10-code for AR (J30) had to be documented at least twice to classify patients as having AR. Descriptive statistics and logistic regression models were used to describe the burden, comorbidities, and treatment of AR.
RESULTS: A total of 111,394 patients (6.2%) had prevalent AR in 2005/2006. In another 60,145 individuals (3.3%) AR was newly diagnosed in 2007 to 2011 (incident cases). Patients with prevalent AR were three times more likely to develop asthma compared to patients without AR (age and sex-adjusted risk ratio (RR) 3.04; 95% confidence interval (95%CI) 2.98 – 3.10). Newly diagnosed recurrent depressive disorder (RR 1.61; 95%CI 1.55 – 1.68), anxiety disorder (RR 1.52; 95%CI 1.48 – 1.56) and ADHD (RR 1.21; 95%CI 1.13 – 1.29) were also related to prevalent AR. Approximately 20% of children and 36% of adults with AR were exclusively treated by general practitioners. Allergy immunotherapy (AIT) was prescribed for 16.4% of AR patients. Subcutaneous immunotherapy was most frequently used (80% of AIT).
CONCLUSIONS: This study highlights the significant burden of AR. Despite the established benefits of AIT to treat AR and prevent asthma this study suggests significant undertreatment. Future research is necessary to develop and implement adequate measures to increase guideline adherence. This article is protected by copyright. All rights reserved.
PMID: 26749452 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
UANews (press release) |
Breathing New Life Into the Study of Asthma
UANews (press release) Today, Martinez, a physician and researcher, is trying to pinpoint asthma's genetic and environmental origins in hopes of finding treatments that prevent people from developing the disease. His efforts are one of the stories to watch from the … |
View full post on asthma – Google News
|
People With Asthma Have Higher Risks Of Acquiring Shingles — Study
Science Times Asthma is a common respiratory condition that affects the lungs and one's breathing, therefore limiting the things that its victim can do. However, it was found in a recent study that those people suffering from asthma also have a higher risk of … |
View full post on asthma – Google News
|
Study: Kids' asthma rates have quieted down
The Sun Chronicle Study: Kids' asthma rates have quieted down – The Sun Chronicle : Stories · Home · Opinion · Columns · Letters to the editor · Cartoon · Lifestyles · Stories · Nostalgia · Go Entertainment · Newspapers in Education · Blogs · eEdition · The Sun Chronicle. |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Fluticasone / Salmeterol; Drug: Placebo; Drug: Advair Diskus 100/50
Sponsors: Roxane Laboratories; Vectura Limited
Completed – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: AZD7594 inhalation powder (200 ?g); Drug: AZD7594 inhalation powder (400 ?g); Drug: AZD7594 pressurized inhalation suspension (200 ?g); Drug: AZD7594 placebo inhalation powder; Drug: AZD7594 placebo pressurized inhalation suspension
Sponsor: AstraZeneca
Not yet recruiting – verified December 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Medical Xpress |
Study Ties Autism Risk to Prenatal Exposure to Asthma Drugs
U.S. News & World Report WEDNESDAY, Jan. 6, 2016 (HealthDay News) — Children whose mothers took certain asthma drugs during pregnancy may have a slightly increased risk of autism, a new study suggests. The study, published online Jan. 6 in Pediatrics, found a connection … Prenatal Exposure to Asthma Drugs Tied to Autism |
View full post on asthma – Google News
|
Study Ties Autism Risk to Prenatal Exposure to Asthma Drugs
HealthDay WEDNESDAY, Jan. 6, 2016 (HealthDay News) — Children whose mothers took certain asthma drugs during pregnancy may have a slightly increased risk of autism, a new study suggests. The study, published online Jan. 6 in Pediatrics, found a connection … |
View full post on asthma – Google News